ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ATXI Avenue Therapeutics Inc

0.1348
-0.0003 (-0.22%)
Apr 18 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 295,245
Bid Price 0.133
Ask Price 0.1348
News -
Day High 0.137299

Low
0.1125

52 Week Range

High
1.28

Day Low 0.131
Company Name Stock Ticker Symbol Market Type
Avenue Therapeutics Inc ATXI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0003 -0.22% 0.1348 18:48:28
Open Price Low Price High Price Close Price Prev Close
0.1351 0.131 0.137299 0.1346 0.1351
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,530 295,245 $ 0.1336637 $ 39,464 - 0.1125 - 1.28
Last Trade Time Type Quantity Stock Price Currency
19:23:17 50 $ 0.1303 USD

Avenue Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.72M 13.25M - 0 -10.38M -0.78 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Avenue Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ATXI Message Board. Create One! See More Posts on ATXI Message Board See More Message Board Posts

Historical ATXI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.14960.1550.11520.13165841,009,807-0.0148-9.89%
1 Month0.16190.16190.11520.1456267906,531-0.0271-16.74%
3 Months0.14280.200.11250.15174911,555,688-0.008-5.60%
6 Months0.600.60450.11250.23817433,789,311-0.4652-77.53%
1 Year1.221.280.11250.25897471,932,917-1.09-88.95%
3 Years64.6583.550.11255.501,787,913-64.52-99.79%
5 Years66.75188.400.11259.951,126,332-66.62-99.80%

Avenue Therapeutics Description

Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. It focuses on developing its product candidate, an intravenous (IV) formulation of tramadol HCI (IV Tramadol), for post-operative acute pain.

Your Recent History

Delayed Upgrade Clock